HCA Healthcare, Inc. (LON: 0J1R)
London
· Delayed Price · Currency is GBP · Price in USD301.22
0.00 (0.00%)
At close: Dec 23, 2024
HCA Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Revenue | 69,621 | 64,968 | 60,233 | 58,752 | 51,533 | 51,336 | Upgrade
|
| Revenue Growth (YoY) | 10.23% | 7.86% | 2.52% | 14.01% | 0.38% | 9.98% | Upgrade
|
| Cost of Revenue | 41,369 | 39,389 | 37,056 | 36,260 | 32,243 | 32,041 | Upgrade
|
| Gross Profit | 28,252 | 25,579 | 23,177 | 22,492 | 19,290 | 19,295 | Upgrade
|
| Selling, General & Admin | 994 | 994 | 976 | 989 | 923 | 855 | Upgrade
|
| Other Operating Expenses | 13,511 | 11,881 | 10,179 | 8,972 | 8,384 | 8,626 | Upgrade
|
| Operating Expenses | 17,750 | 15,952 | 14,124 | 12,814 | 12,028 | 12,077 | Upgrade
|
| Operating Income | 10,502 | 9,627 | 9,053 | 9,678 | 7,262 | 7,218 | Upgrade
|
| Interest Expense | -2,024 | -1,938 | -1,741 | -1,566 | -1,584 | -1,824 | Upgrade
|
| Earnings From Equity Investments | 41 | 22 | 45 | 113 | 54 | 43 | Upgrade
|
| EBT Excluding Unusual Items | 8,519 | 7,711 | 7,357 | 8,225 | 5,732 | 5,437 | Upgrade
|
| Gain (Loss) on Sale of Assets | 216 | -5 | 1,301 | 1,620 | -7 | 18 | Upgrade
|
| Other Unusual Items | - | - | -78 | -12 | -295 | -211 | Upgrade
|
| Pretax Income | 8,735 | 7,706 | 8,580 | 9,833 | 5,430 | 5,244 | Upgrade
|
| Income Tax Expense | 1,903 | 1,615 | 1,746 | 2,112 | 1,043 | 1,099 | Upgrade
|
| Earnings From Continuing Operations | 6,832 | 6,091 | 6,834 | 7,721 | 4,387 | 4,145 | Upgrade
|
| Minority Interest in Earnings | -903 | -849 | -1,191 | -765 | -633 | -640 | Upgrade
|
| Net Income | 5,929 | 5,242 | 5,643 | 6,956 | 3,754 | 3,505 | Upgrade
|
| Net Income to Common | 5,929 | 5,242 | 5,643 | 6,956 | 3,754 | 3,505 | Upgrade
|
| Net Income Growth | 3.73% | -7.11% | -18.88% | 85.30% | 7.10% | -7.45% | Upgrade
|
| Shares Outstanding (Basic) | 262 | 272 | 290 | 323 | 338 | 341 | Upgrade
|
| Shares Outstanding (Diluted) | 266 | 276 | 295 | 329 | 344 | 348 | Upgrade
|
| Shares Change (YoY) | -5.09% | -6.19% | -10.37% | -4.32% | -1.33% | -1.99% | Upgrade
|
| EPS (Basic) | 22.60 | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | Upgrade
|
| EPS (Diluted) | 22.31 | 18.97 | 19.15 | 21.16 | 10.93 | 10.07 | Upgrade
|
| EPS Growth | 9.31% | -0.94% | -9.50% | 93.60% | 8.54% | -5.53% | Upgrade
|
| Free Cash Flow | 5,880 | 4,687 | 4,127 | 5,382 | 6,397 | 3,444 | Upgrade
|
| Free Cash Flow Per Share | 22.12 | 16.96 | 14.01 | 16.37 | 18.62 | 9.89 | Upgrade
|
| Dividend Per Share | 2.580 | 2.400 | 2.240 | 1.920 | 0.430 | 1.600 | Upgrade
|
| Dividend Growth | 9.32% | 7.14% | 16.67% | 346.51% | -73.13% | 14.29% | Upgrade
|
| Gross Margin | 40.58% | 39.37% | 38.48% | 38.28% | 37.43% | 37.59% | Upgrade
|
| Operating Margin | 15.08% | 14.82% | 15.03% | 16.47% | 14.09% | 14.06% | Upgrade
|
| Profit Margin | 8.52% | 8.07% | 9.37% | 11.84% | 7.28% | 6.83% | Upgrade
|
| Free Cash Flow Margin | 8.45% | 7.21% | 6.85% | 9.16% | 12.41% | 6.71% | Upgrade
|
| EBITDA | 13,747 | 12,704 | 12,022 | 12,531 | 9,983 | 9,814 | Upgrade
|
| EBITDA Margin | 19.75% | 19.55% | 19.96% | 21.33% | 19.37% | 19.12% | Upgrade
|
| D&A For EBITDA | 3,245 | 3,077 | 2,969 | 2,853 | 2,721 | 2,596 | Upgrade
|
| EBIT | 10,502 | 9,627 | 9,053 | 9,678 | 7,262 | 7,218 | Upgrade
|
| EBIT Margin | 15.08% | 14.82% | 15.03% | 16.47% | 14.09% | 14.06% | Upgrade
|
| Effective Tax Rate | 21.79% | 20.96% | 20.35% | 21.48% | 19.21% | 20.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.